The long-term objective of this research program is the elucidation of the molecular mechanisms of hepatic regeneration in pediatric liver diseases. The specific goals of this project are to determine the functional role of adipsin expression and complement pathway activation in the regulation of hepatic regeneration. Recently, we reported that the early regenerating liver transiently activates a program of adipocytic gene expression and hepatocellular fat accumulation, and that disruption of this adipogenic response results in impaired regeneration. These observations suggest that this adipogenic program is regulated during and essential for normal liver regeneration. One of the genes identified as induced as part of this response in regenerating liver is adipsin. Adipsin, also known as complement factor D, is a unique serine protease whose only known substrate target is C3b-bound complement factor B, which it cleaves during complement alternative pathway activation. Adipsin and factor B are not required for complement classical pathway activation. Complement factor 3 (C3) is the principal target of activation of both pathways. Together, these observations suggest that the complement alternative pathway may be an important regulator of the hepatic regenerative response. In support of this, our preliminary data show that liver regeneration is abnormal in both CS-deficient- and adipsin-deficient-mice. Surprisingly, our data indicate that the regenerative response is more severely disrupted in adipsin-deficient animals than in C3-null mice. Based on these data, we hypothesize that hepatic adipogenic changes and complement alternative pathway activation are essential for initiation of normal liver regeneration and furthermore that adipsin may have complement-independent activity during liver regeneration. In order to test this hypothesis, we propose the following aims: (1) To test whether complement cascade activation is essential for normal liver regeneration and determine the mechanistic basis of this requirement; (2) To test whether adipsin expression and complement alternative pathway activation are required for normal liver regeneration; and, (3) To test whether adipsin exhibits complement cascade-independent activity during liver regeneration. The public health implication of these studies relates to their likelihood of increasing our understanding of the mechanisms that regulate hepatic regeneration in response to liver injury, and, ultimately, leading to the development of better diagnostic and therapeutic tools for managing human liver diseases.
| Huang, Jiansheng; Rudnick, David A (2014) Elucidating the metabolic regulation of liver regeneration. Am J Pathol 184:309-21 |
| Rudnick, David A; Davidson, Nicholas O (2012) Functional Relationships between Lipid Metabolism and Liver Regeneration. Int J Hepatol 2012:549241 |
| Huang, Jiansheng; Glauber, Martin; Qiu, Zhaohua et al. (2012) The influence of skeletal muscle on the regulation of liver:body mass and liver regeneration. Am J Pathol 180:575-82 |
| Gazit, Vered; Huang, Jiansheng; Weymann, Alexander et al. (2012) Analysis of the role of hepatic PPARýý expression during mouse liver regeneration. Hepatology 56:1489-98 |
| Gazit, Vered; Weymann, Alexander; Hartman, Eric et al. (2010) Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology 52:2109-17 |
| Ge, Jingping; Rudnick, David A; He, Jun et al. (2010) Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol Cell Biol 30:413-22 |
| Rudnick, David A; Dietzen, Dennis J; Turmelle, Yumirle P et al. (2009) Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant 13:223-30 |
| Weymann, Alexander; Hartman, Eric; Gazit, Vered et al. (2009) p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology 50:207-15 |
| Clark, Amelia; Weymann, Alexander; Hartman, Eric et al. (2008) Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol 45:3125-32 |
| Turmelle, Yumirle P; Shikapwashya, Olga; Tu, Shu et al. (2006) Rosiglitazone inhibits mouse liver regeneration. FASEB J 20:2609-11 |
